Zarate Yuri A, Bosanko Katherine, Derar Nada, Fish Jennifer L
Division of Genetics and Metabolism, University of Kentucky, Lexington, Kentucky, USA.
Department of Pediatrics, Section of Genetics and Metabolism, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Clin Genet. 2024 Aug;106(2):209-213. doi: 10.1111/cge.14540. Epub 2024 May 1.
SATB2-associated syndrome (SAS, glass syndrome, OMIM#612313) is a neurodevelopmental autosomal dominant disorder with frequent craniofacial abnormalities including palatal and dental anomalies. To assess the role of Satb2 in craniofacial development, we analyzed mutant mice at different stages of development. Here, we show that Satb2 is broadly expressed in early embryonic mouse development including the mesenchyme of the second and third arches. Satb2 mutant mice exhibit microglossia, a shortened lower jaw, smaller trigeminal ganglia, and larger thyroids. We correlate these findings with the detailed clinical phenotype of four individuals with SAS and remarkable craniofacial phenotypes with one requiring mandibular distraction in childhood. We conclude that the mouse and patient data presented support less well-described phenotypic aspects of SAS including mandibular morphology and thyroid anatomical/functional issues.
SATB2相关综合征(SAS,格拉斯综合征,OMIM#612313)是一种神经发育性常染色体显性疾病,常伴有颅面异常,包括腭部和牙齿异常。为了评估Satb2在颅面发育中的作用,我们分析了不同发育阶段的突变小鼠。在此,我们表明Satb2在小鼠胚胎早期广泛表达,包括第二和第三鳃弓的间充质。Satb2突变小鼠表现出小舌、下颌缩短、三叉神经节较小以及甲状腺较大。我们将这些发现与四名SAS患者的详细临床表型以及一名在儿童期需要下颌骨牵引的显著颅面表型相关联。我们得出结论,所呈现的小鼠和患者数据支持了SAS中较少描述的表型方面,包括下颌形态以及甲状腺解剖/功能问题。